14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Nov 04, 2016 $25.61 $28.78 $24.87 $27.49 530 000
Nov 03, 2016 $27.33 $27.39 $24.77 $24.86 355 100
Nov 02, 2016 $28.23 $28.91 $27.34 $27.36 243 400
Nov 01, 2016 $28.09 $28.98 $27.62 $28.30 274 200
Oct 31, 2016 $27.54 $28.59 $27.42 $28.03 266 800
Oct 28, 2016 $27.77 $28.12 $26.78 $27.48 268 800
Oct 27, 2016 $27.48 $29.19 $27.46 $28.00 644 300
Oct 26, 2016 $27.69 $27.98 $26.43 $26.92 198 300
Oct 25, 2016 $28.35 $28.44 $27.57 $27.64 182 000
Oct 24, 2016 $29.39 $29.40 $28.23 $28.25 211 100
Oct 21, 2016 $30.04 $30.23 $29.11 $29.20 152 700
Oct 20, 2016 $29.86 $30.41 $29.55 $30.19 249 000
Oct 19, 2016 $30.06 $30.19 $29.52 $29.94 224 900
Oct 18, 2016 $30.28 $30.52 $29.81 $30.02 124 300
Oct 17, 2016 $29.73 $30.16 $29.09 $29.86 177 600
Oct 14, 2016 $30.64 $30.64 $29.74 $29.74 301 800
Oct 13, 2016 $30.35 $31.07 $30.01 $30.34 257 400
Oct 12, 2016 $33.69 $33.69 $30.75 $30.76 226 000
Oct 11, 2016 $34.59 $35.17 $33.49 $33.73 330 800
Oct 10, 2016 $33.89 $35.36 $33.78 $35.06 236 200
Oct 07, 2016 $34.00 $34.00 $32.96 $33.47 289 800
Oct 06, 2016 $35.68 $35.68 $33.84 $33.95 205 900
Oct 05, 2016 $35.38 $36.48 $35.16 $36.22 311 500
Oct 04, 2016 $35.64 $36.22 $34.29 $35.31 124 200
Oct 03, 2016 $36.00 $36.02 $34.75 $35.56 240 500
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT